Gene expression of types I and III collagen, decorin, matrix metalloproteinases and tissue inhibitors of metalloproteinases in skin fibroblasts from patients with systemic sclerosis

Archives of Dermatological Research

Volumn 289, Issue 10, 1997, Pages 567-572

  Kuroda, K ^a   Shinkai, H ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Collagen; Decorin; Matrix metalloproteinases; Systemic sclerosis; Tissue inhibitors of metalloproteinases

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 3; COLLAGENASE; DECORIN; GELATINASE A; MESSENGER RNA; PROCOLLAGEN; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; SKIN FIBROBLAST; SYSTEMIC SCLEROSIS;

ADULT; COLLAGEN; EXTRACELLULAR MATRIX PROTEINS; FEMALE; FIBROBLASTS; GENE EXPRESSION; HUMANS; MALE; METALLOENDOPEPTIDASES; MIDDLE AGED; PROTEOGLYCANS; SCLERODERMA, SYSTEMIC; SKIN; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 0030668134     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004030050241     Document Type: Article

References (42)

1. Fleischmajer R (1993) Localized and systemic scleroderma. In: Lapiere CM, Krieg T (eds) Connective tissue diseases of the skin. Marcel Dekker, New York, pp 295-313
2. LeRoy EC (1974) Increased collagen synthesis by scleroderma skin fibroblasts in vivo. J Clin Invest 54:880-889
3. Uitto J, Bauer EA, Eisen AZ (1979) Scleroderma. Increased biosynthesis of triple-helical type I and type III procollagens associated with unaltered expression of collagenase by skin fibroblasts. J Clin Invest 64:921-923
4. Rodnan GP, Lipinski E, Luksick J (1979) Skin thickness and collagen content in progressive systemic sclerosis and localized scleroderma. Arthritis Rheum 22:130-140
5. Krieg T, Luderschmidt C, Weber L, Müller PK, Braun-Falco O (1981) Scleroderma fibroblusts: some aspects of in vitro assessment of collagen synthesis. Arch Dermatol Res 270:263-272
6. Peltonen J, Kähäri L, Uitto J, Jimenez SA (1990) Increased expression of type VI collagen genes in systemic sclerosis. Arthritis Rheum 33:1829-1835
7. Rudnicka L, Varga J, Christiano AM, Iozzo RV, Jimenez SA, Uitto J (1994) Elevated expression of type VII collagen in the skin of patients with systemic sclerosis. J Clin Invest 93:1709-1715
8. Xu W, Leroy EC, Smith EA (1991) Fibronectin release by systemic sclerosis and normal dermal fibroblasts in response to TGF-β. J Rheumatol 18:241-246
9. Vogel KG, Trotter JA (1987) The effect of proteoglycans on the morphology of collagen fibrils formed in vitro. Collagen Rel Res 7:105-114
10. Scott JE, Haigh M (1988) Identification of specific binding site for keratan sulphate proteoglycans and chondroitin-dermatan sulphate proteoglycans on collagen fibrils in cornea by the use of cupromeronic blue in 'critical-electrolyte-concentration' techniques. Biochem J 253:607-610
11. Pulkkinen L, Kainulainen K, Krusius T, Mäkinen P, Schollin J, Gustavsson KH, Peltonen L(1990) Deficient expression of the gene coding for decorin in a lethal form of Martan syndrome. J Biol Chem 265:17780-17785
12. Beavun LA, Quentin-Hoffmann E, Schönherr E, Snigula F, Leroy JG, kresse H (1993) Deficient expression of decorin in infantile progeroid patients. J Biol Chem 268:9856-9862
13. Yamaguchi Y, Mann DM, Ruoslahti E (1990) Negative regulation of transforming growth factor-β by the proteoglycan decorin. Nature 346:281-284
14. Woessner JF (1991) Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 5:2145-2154
15. Eeckhout Y, Vaes G (1977) Further studies on the activation of procollagenase, the latent precursor of bone collagenase. Biochem J 166:21-31
16. Suzuki K, Enghild JJ, Morodomi T, Salvesen G, Nagase H (1990) Mechanisms of activation of tissue procollagenase by matrix metalloproteinase 3 (stromelysin). Biochemistry 29: 10261-10270
17. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23:581-590
18. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger T, Rowell T, Wollheim F (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202-205
19. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159
20. Chu ML, Myers JC, Bernhard MP, Ding JF, Ramirez F (1982) Cloning and characterization of five overlapping cDNAs specific for the human pro-α1 (I) collagen chain. Nucleic Acids Res 10:5925-5934
21. Myers JC, Chu ML, Faro SH, Clark WJ, Proekop DJ, Ramirez F (1981) Cloning a cDNA for the pro-α2 chain of human type 1 collagen. Proc Natl Acad Sci USA 78:3516-3520
22. Miskulin M, Dalgleish R, Kluve-Beckerman B, Rennard S, Tolstoshev P, Bruntly M, Crystal R (1986) Human type III collagen gene expression is coordinately modulated with the type I collagen genes during fihroblast growth. Biochemistry 25: 1408-1413
23. Krusius T, Ruoslahti E (1986) Primary structure of un extracellular matrix proleoglycan core protein deduced from cloned cDNA. Proc Natl Acad Sci USA 83:7683-7687
24. Goldberg GI, Wilhelm SM, Kronberger A, Bauer EA, Grant GA, Eisen AZ (1986) Human fibroblasts collagenuse. J Biol Chem 261:6600-6605
25. Collier IE, Wilhelm SM, Eisen AZ, Manner BL, Grant GA, Seltzer JL, Kronberger A, He C, Bauer EA, Goldberg GI (1988) H-ras oneogene-transformed human bronchial epithelial cells (TBE-I) secrete a single metalloprotease capable of degrading basement membrane collagen. J Biol Chem 263:6579-6587
26. Saus J, Quinones S, Otani Y, Nagase H, Harris ED, Kurkinen M (1988) The complete primary structure of human matrix metulloproteinase-3. J Biol Chem 263:6742-6745
27. Carmichel DF, Sommer A, Thompson RC, Anderson DC, Smith CG, Welgus HG, Stricklin GP (1986) Primary structure and cDNA cloning of human fibroblast collagenase inhibitor. Proc Nail Acad Sci USA 83:2407-2411
28. Sietler-Stevenson WG, Brown PD, Onisto M, Levy AT, Liotta L (1990) Tissue inhibitor of metalloproteinases-2 (TIMP-2) mRNA expression in the tumor cell lines and human tumor tissues. J Biol Chem 265:13933-13938
29. Nagai M, Hiramutsu R, Kaneda T, Hayasuka N, Arimura H, Nishida M, Suyama T (1985) Molecular cloning of cDNA coding for human preprourokinase. Gene 36:183-185
30. Fisher R, Waller E, Grossi G, Thompson D, Tizard R, Schleuning WD (1985) Isolation and characterization of the human tissue-type plusminogen activator structural gene including its 5′ Hanking region. J Biol Chem 260:11223-11230
31. Arcrari P, Martinelli R, Salvutore F (1984) The complete sequence of a full length cDNA for human liver glyeeraidehyde3-phosphale dehydrogenase: evidence for multiple mRNA species. Nucleic Acids Res 12:9179-9189
32. Sappino AP, Musouyé I, Saurai JH, Gabbiani G (1990) Smooth muscle differentiation in sclerodermu fibroblastic cells. Am J Pathol 137:585-591
33. Kirk TZ, Mark ME, Chuu CC, Chuu BH, Mayer MD (1995) Myufibroblusts from scleroderma skin synthesize elevated levels of collagen and tissue inhibitor of metalloproteinase (TIMP-1) with two forms of TIMP-1. J Biol Chem 270:3423-3428
34. Takeda K, Hatamochi A, Ueki H, Nakata M, Oishi Y (1994) Decreased collagenase expression in cultured systemic sclerosis fibroblasts. J Invest Dermatol 103:359-363
35. Vogel KG, Paulsson M, Heinegard D (1984) Specific inhibition of type I and type II collagen fibrillogenesis by the small proteoglycan of tendon. Biochem J 223:587-597
36. Vuorio T, Kähäri VM, Black C, Vuorio E (1991) Expression of osteonectin, decorin, and transforming growth factor genes in fibroblasts cultured from patients with systemic sclerosis and morphea. J Rheumatol 18:247-251
37. Izumi T, Tajima S, Nishikawa T (1995) Stimulated expression of decorin and the decorin gene in fibroblasts cultured from patients with localized scleroderma. Arch Dermatol Res 287: 417-420
38. Oksala O, Salo T, Tamai R, Häkkinen L, Jalkanen M, Inki P, Larjava H (1995) Expression of proteoglycans and hyaluromm during wound healing. J Histochem Cytochem 43:125-135
39. Tan EML, Hoffren J, Rouda S, Greenbaum S, Fox JW, Moore JH, Dodge GR (1993) Decorin. versican, and biglycan gene expression by keloid and normal fibroblasts: differential regulation by basic fibroblast growth factor. Exp Cell Res 209: 200-207
40. LeRoy EC, Smith EA, Kanalen MB, Trojanowska M, Silver RM (1989) A strategy for determining the pathogenesis of systemic sclerosis. Is transforming growth factor β the answer? Arthritis Rheum 32:817-825
41. Sundborg Cl, Berman MA, Andrews BS, Friou GJ (1985) Interleukin-1 production by mononuclear cells from patients with scleroderma. Clin Exp Immunol 60:294-302
42. Kikuchi K, Hurtl CW, Smith EA, LeRoy EC. Trojanowska M (1992) Direct demonstration of transcriptional activation of collagen gene expression in systemic sclerosis fibroblasts: insensitivity toTGF-β1 stimulation. Biochem Biophys Res Commun 187:45-50